Results 141 to 150 of about 164,596 (212)

Integrated metabolome and transcriptome analysis reveals ferroptosis involvement in cisplatin resistance of esophageal squamous cancer cell. [PDF]

Comput Struct Biotechnol J
Song K, Zhang T, Xie X, Liao D, Wu L, Jiang P.   +5 more
europepmc   +1 more source

MEF2C induces intrinsic apoptosis and reverses cisplatin resistance in A2780 ovarian cancer cell line. [PDF]

BMC Cancer
Fadavi Z, Alizadeh H, Mowla SJ, Soltani BM.   +3 more
europepmc   +1 more source

CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells. [PDF]

Cell Death Discov
Chen C, Zhang F, Shen J, Zheng Q, Zhang Z, Lu S, Liu L, Zhu T, Du Y, Guan Y.   +9 more
europepmc   +1 more source

Cisplatin resistance

, 1995
openaire   +1 more source

Epithelial‑mesenchymal plasticity and cisplatin resistance in germ cell tumors: Mechanisms and emerging therapeutic strategies (Review). [PDF]

Int J Oncol
Gomes ESB, De Souza TM, Oliveira ALP, Bezerra AFSP, Cardoso IIV, Silva L, Lopes LF, Rosa MN, Pinto MT.   +8 more
europepmc   +1 more source

Clinofibrate Disrupts the SNORA80B/YTHDC1-Driven M6A Modification to Suppress Cholesterol Metabolism and Cisplatin Resistance in ESCC. [PDF]

Adv Sci (Weinh)
Yuan H, Ge G, Liu L, Hu S, Tian M, Nie Y, Zhao Z, Song Y.   +7 more
europepmc   +1 more source

Curcumol overcomes cisplatin resistance and rewires glycolysis-H3K9la-ORC6 axis to trigger ferroptosis in bladder cancer. [PDF]

Chin J Cancer Res
Zhang F, Yang Y, Zhang R, Hu H, Zhou C, Wang J, Wu R, Li E, Cho WC, Zhang D, Zhang Q, Feng D.   +11 more
europepmc   +1 more source

Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models. [PDF]

Sci Rep
Tamburello M, Boldini C, Abate A, Salvi V, Valcamonico F, Laganà M, Cosentini D, Suardi NR, Mirabella G, Altieri B, Sigala S.   +10 more
europepmc   +1 more source

Mechanistic study of the role of emodin in targeting and inhibiting the Rap1 signaling pathway to regulate epithelial-mesenchymal transition and reverse cisplatin resistance in hepatocellular carcinoma. [PDF]

Transl Cancer Res
Zhang R, Jiao Y, Wang S, Wang L, Leng Y, Xiong Z, Yang M.   +6 more
europepmc   +1 more source

E2F7 promotes ESCC progression and cisplatin resistance through transcriptional activation of DVL3 and the Wnt signaling pathway. [PDF]

World J Surg Oncol
Li X, Chen L, Xu T, Yan Z.
europepmc   +1 more source